You are here: Industry Insights > Bristol Myers Squibb

News List

Prellis, Bristol Myers Squibb collaborate to discover antibodies pharmaceutical-business-review
January 14, 2022
Prellis Biologics and Bristol Myers Squibb have signed a multi-target collaboration and license agreement to discover antibodies.
BMS Completes Sale of Couvet Site to WuXi STA contractpharma
August 05, 2021
Bristol Myers Squibb has completed the previously announced sale of its manufacturing facility in Couvet, Switzerland, to WuXi STA, a subsidiary of WuXi AppTec.
Bristol Myers Squibb Receives European Commission Approval for Onureg® as Oral Therapy for Adults with Leukemia americanpharmaceuticalreview
June 23, 2021
Bristol Myers Squibb announced that the European Commission (EC) has granted full Marketing Authorization for Onureg® (azacitidine tablets) as maintenance therapy in adult patients with acute myeloid leukemia (AML) who achieved complete remission (CR) ...
EC Approval for Opdivo Plus Yervoy as First-Line Treatment for Unresectable Malignant Pleural Mesothelioma americanpharmaceuticalreview
June 04, 2021
Bristol Myers Squibb announced that the European Commission (EC) has approved Opdivo (nivolumab) plus Yervoy (ipilimumab) for the first-line treatment of adults with unresectable malignant pleural mesothelioma (MPM).
U.S. FDA Approves an Oral Treatment for Adults with Ulcerative Colitis americanpharmaceuticalreview
June 02, 2021
Bristol Myers Squibb announced that the U.S. FDA approved Zeposia® (ozanimod) 0.92 mg for the treatment of adults with moderately to severely active ulcerative colitis (UC), a chronic inflammatory bowel disease (IBD).
Cross-industry alliance launches to increase awareness of cell and gene therapies in the UK pharmatimes
May 19, 2021
A new cross-industry alliance between leading pharma and biotech companies has launched in a bid to raise awareness and boost understanding of cell and gene therapies in the UK.
DarwinHealth Announces a Research Collaboration with Bristol Myers Squibb for a Novel Cancer Target Discovery (NCTI) Initiative prnasia
May 07, 2021
DarwinHealth, a New York City-based biotechnology company, announced a scientific research collaboration with Bristol-Myers Squibb Company.
Bristol Myers Squibb revenues increase in Q1 2021 pharmaceutical-technology
May 06, 2021
Bristol Myers Squibb has reported revenues of $11.1bn for the first quarter of this year, which represents an increase of 3%, compared to $10.78bn in the first quarter last year.
Syngene extends research partnership with Bristol Myers Squibb until 2030 expresspharma
April 28, 2021
The extension envisions a 40 per cent increase in the number of scientists and the addition of a new 50,000 sq. ft. dedicated laboratory space.
Bristol Myers Squibb Invests in Cell Therapy Ops contractpharma
April 28, 2021
Bristol Myers Squibb has selected Leiden, Netherlands to house a new cell therapy manufacturing site in Europe, leveraging the growing life sciences region near Amsterdam and convenient access to transportation for shipping patient cells.

Previous page 1 2 3 4 Next page